Navigation Links
James Roosevelt, Jr. Joins Inverness Medical Innovations' Board of Directors
Date:2/9/2009

WALTHAM, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that James Roosevelt, Jr., president and chief executive officer of Tufts Health Plan, was elected to the company's board of directors.

President Obama recently selected Mr. Roosevelt as part of his transition team to co-chair a review of the Social Security Administration. He serves as chairman of the board of directors for Massachusetts Association of Health Plans, and as a member of the board of directors at America's Health Insurance Plans, Emmanuel College and the Kenneth B. Schwartz Center.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.


'/>"/>
SOURCE Inverness Medical Innovations
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. James B. Hawkins Appointed to IRIDEX Board of Directors
2. James Cracknell Launches Siemens Stroke for Stroke Week
3. Marianjoy Rehabilitation Hospital to Receive James Brady Award From Brain Injury Association of Illinois
4. HealthCoach Welcomes James Herrera as Vice President of Consulting
5. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
6. Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
7. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
8. Bobby Rush Revue and James Super Chikan Johnson Announced for Post-Race Concert
9. ATS Medical Appoints James L. Cox, M.D. as Medical Director
10. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
11. James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his ... the quarterback position. The former overall number one pick in the 2001 NFL Draft, ... He holds the record for the most career rushing yards by a quarterback (6,109) ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Educational Research Association’s Outstanding Public Communication of Education Research Award. The award honors ... including education communities. It recognizes a scholar who has demonstrated the capacity to ...
(Date:4/24/2017)... ... , ... Sean Fay is the undisputed king of the infomercial. With clients ... George Foreman Grill (which sold more than 100 million units worldwide), he has created ... Now, due to changes in the broadcast media landscape, the once ever-present infomercial has ...
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: